The Claim
In women with major depressive disorder taking escitalopram, 8 weeks of creatine monohydrate augmentation at 10g/day significantly improves depressive symptoms compared to placebo, with greater increases in prefrontal N-acetylaspartate and enhanced rich club hub connectivity in the structural brain network.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with major depressive disorder taking escitalopram, taking 10 grams of creatine monohydrate daily for 8 weeks leads to greater improvement in depressive symptoms than a placebo, along with measurable increases in prefrontal N-acetylaspartate and stronger connectivity in key brain network hubs.
See the scientific wording
In women with major depressive disorder taking escitalopram, 8 weeks of creatine monohydrate augmentation (10g/day) significantly improves depressive symptoms compared to placebo, with greater increases in prefrontal N-acetylaspartate and enhanced rich club hub connectivity in the structural brain network, suggesting a potential role for brain energy metabolism and network organization in antidepressant response.
Creatine boosts the brain's energy reserves, allowing neurons to produce more N-acetylaspartate and rebuild stronger connections between key network hubs, which improves mood regulation.
What the research says
1 studyIn women with depression taking a common antidepressant, adding creatine for 8 weeks made them feel better than adding a sugar pill—and their brains showed signs of improved energy use and better-connected networks. This suggests creatine may help the brain work better when fighting depression.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.